82% of Pharma Market Lacks Direct Price Regulation, Parliamentary Panel Exposes Excessive Trade Margins
R. Suryamurthy For millions of Indian households, the cost of illness increasingly extends beyond disease itself as Parliament has questioned a drug pricing regime that leaves nearly 82% of the…
